How effective commercialisation will benefit your AgTech startup
Posted 2nd July 2018 by Jane Williams
Over the past thirty years, Donald R. Marvin, President and CEO of Concentric, has established an impressive track record for building exceptional value for stakeholders at several life science and agri-food companies. Formerly New Jersey’s CFO of the year, he has raised over $350 million in both private and public financing and completed nearly a dozen M&A transactions for his former companies.
Collaborations in Microbiome Research: An Academic Scientist’s Dilemma
Posted 10th April 2017 by Jane Williams
Knowledge is the key to innovation. When companies and universities collaborate to push the frontiers of knowledge, they become a powerful engine for innovation and economic growth (Santoro & Betts, 2002).
Disease, Ageing and Lifestyle: Considerations from the Microbiome Forum
Posted 21st December 2016 by Jane Williams
At the 3rd Microbiome R&D and Business Collaboration Forum: Europe, topics covered the impact of microbiomes on human health and disease, developing therapeutics, and investment into the microbiome. Duc H. Le, the UK Editor-in-Chief of EBioMedicine, summarises some of the presentations that took place.
5 Things You Need to Know About Venture Capital Firms
Posted 5th December 2016 by Jane Williams
As a start-up looking for funding, every venture capital firm might seem the same, but all money is not created equal. When you present yourself to a venture capitalist, you’re selling to a business. This means you need to get to know their business and what motivates their decision-makers.
How to get Funding for Your Human Microbiome Startup
Posted 14th November 2016 by Jane Williams
The vast amount of research into the human microbiome is attracting new companies to the field and the race to translate scientific data into viable products has begun. Financial interest in the microbiome is at an all-time high, giving many scientists the opportunity to start their own business as product development or service companies.